Jim Simons Infinity Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.14 - $0.24 $17,248 - $29,568	123,200 Added 52.43%	358,200 $75,000
Q1 2023 May 12, 2023	SELL	$0.16 - $0.74 $29,536 - $136,604	-184,600 Reduced 43.99%	235,000 $38,000
Q4 2022 Feb 13, 2023	SELL	$0.46 - $1.21 $115,465 - $303,724	-251,012 Reduced 37.43%	419,600 $233,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $53,425 - $153,938	-90,552 Reduced 11.9%	670,612 $798,000
Q2 2022 Aug 12, 2022	SELL	$0.49 - $1.2 $96,185 - $235,555	-196,296 Reduced 20.5%	761,164 $481,000
Q1 2022 May 13, 2022	BUY	$0.85 - $2.4 $502,405 - $1.42 Million	591,065 Added 161.32%	957,460 $1.09 Million
Q4 2021 Feb 11, 2022	BUY	$1.86 - $3.36 $589,610 - $1.07 Million	316,995 Added 641.69%	366,395 $824,000
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $1.02 Million - $2.56 Million	-669,967 Reduced 93.13%	49,400 $169,000
Q2 2021 Aug 13, 2021	SELL	$2.66 - $3.47 $1.11 Million - $1.45 Million	-416,700 Reduced 36.68%	719,367 $2.15 Million
Q1 2021 May 13, 2021	SELL	$1.98 - $5.36 $2.14 Million - $5.79 Million	-1,079,907 Reduced 48.73%	1,136,067 $3.67 Million
Q4 2020 Feb 10, 2021	BUY	$1.05 - $2.77 $450,493 - $1.19 Million	429,041 Added 24.01%	2,215,974 $4.7 Million
Q3 2020 Nov 13, 2020	BUY	$0.82 - $1.34 $128,161 - $209,435	156,295 Added 9.58%	1,786,933 $2.09 Million
Q2 2020 Aug 13, 2020	BUY	$0.77 - $1.13 $188,822 - $277,103	245,224 Added 17.7%	1,630,638 $1.48 Million
Q1 2020 May 14, 2020	BUY	$0.69 - $1.52 $87,699 - $193,193	127,101 Added 10.1%	1,385,414 $1.16 Million
Q4 2019 Feb 13, 2020	BUY	$0.88 - $1.29 $120,888 - $177,211	137,373 Added 12.26%	1,258,313 $1.21 Million
Q3 2019 Nov 13, 2019	BUY	$1.03 - $1.75 $122,502 - $208,134	118,934 Added 11.87%	1,120,940 $1.16 Million
Q2 2019 Aug 12, 2019	BUY	$1.43 - $1.87 $158,452 - $207,207	110,806 Added 12.43%	1,002,006 $1.8 Million
Q1 2019 May 14, 2019	BUY	$1.18 - $1.91 $81,774 - $132,363	69,300 Added 8.43%	891,200 $1.68 Million
Q4 2018 Feb 13, 2019	BUY	$1.01 - $2.78 $830,119 - $2.28 Million	821,900 New	821,900 $970,000

Others Institutions Holding INFI

# of Institutions

Shares Held

1.26M

Call Options Held

Put Options Held

View Full List

About INFINITY PHARMACEUTICALS, INC.

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

More about INFI

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account